Videolaryngoscopic Intubation Using Macintosh vs.Hyperangulated Blades in Patients With Expected Difficult Intubation

September 24, 2023 updated by: Universitätsklinikum Hamburg-Eppendorf

Videolaryngoscopy-guided Intubation Using Macintosh Versus Hyperangulated Blades in Patients With Expected Difficult Intubation Undergoing Ear, Nose and Throat Surgery or Maxillofacial Surgery a Randomized Controlled Trial

Videolaryngoscopy-guided intubation has become widespread as a means of preventing major complications relating to airway management by improving the glottic view, increasing the first attempt success rate, likely reduce rates of hypoxemic events, while reducing the rate of airway trauma. However, as randomized controlled studies in patients with anticipated difficult intubation undergoing ear nose and throat (ENT) or oral and maxillofacial (OMF) surgery are lacking, it is still unknown if hyperangulated blades improve glottic view and if their use translates into faster intubation. The primary aim of this randomized controlled trial is to compare the percentage of glottic opening (POGO) between hyperangulated blades and Macintosh blades in patients with expected difficult intubation undergoing ENT or OMF surgery who require transoral tracheal intubation. Secondary aims are to compare secondary outcome measures such as time variables, indicators for difficult and successful intubation, number of attempts, view conditions, difficult airway classifications and adverse events between both blade types.

Study Overview

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • University Medical Center Hamburg-Eppendorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients requiring general anesthesia with transoral tracheal intubation for elective ear, nose and throat or maxillofacial surgery
  • Expected difficult intubation
  • Age ≥ 18

Exclusion Criteria:

  • Pregnant or breastfeeding woman
  • Planned awake tracheal intubation (without deep anesthesia or neuromuscular blocking agents)
  • Required transnasal tracheal intubation (e.g. for surgical reasons)
  • Special tubes required for surgical reasons ( e.g. double lumen tube)
  • Denial of consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Tracheal intubation facilitated by a hyperangulated videolaryngoscope (C-MAC D-Blade)
Intubation using a hyperangulated videolaryngoscope
Other Names:
  • C-MAC D-Blade
  • Storz
Active Comparator: Control group
Tracheal intubation facilitated by a videolaryngoscope with a Macintosh type blade (C-MAC)
Intubation using a Macintosh videolaryngoscope
Other Names:
  • Storz
  • C-MAC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of glottic opening (POGO)
Time Frame: 1 hour
Grading of the best view obtained during laryngoscopy (%)
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to successful tracheal intubation (seconds)
Time Frame: 1 hour
Recorded during airway management
1 hour
Time to successful first attempt intubation (seconds)
Time Frame: 1 hour
Recorded during airway management
1 hour
Cormack-Lehane grade
Time Frame: 1 hour
Grading of the best view obtained during laryngoscopy (I [best] to IV [worst])
1 hour
Impaired view (vocal cords cannot be visualized by laryngoscopy)
Time Frame: 1 hour
Number of participants with impaired view observed during airway management
1 hour
Difficult laryngoscopy
Time Frame: 1 hour
Number of participants with difficult laryngoscopy as defined in current guidelines
1 hour
Difficult intubation
Time Frame: 1 hour
Number of participants with difficult tracheal intubation as defined in current guidelines
1 hour
Transition to a different tracheal intubation technique
Time Frame: 1 hour
Number of participants in whom the airway operator decided to convert to an alternative intubation technique
1 hour
Tracheal introducer
Time Frame: 1 hour
Number of participants in whom the airway operator decided to use a tracheal introducer
1 hour
Successful first attempt
Time Frame: 1 hour
Number of participants with successful tracheal intubation with only one attempt
1 hour
Overall success of intubation
Time Frame: 1 hour
Number of participants with successful tracheal intubation regardless of the the number of attempts
1 hour
Difficulty of videolaryngoscope-guided intubation
Time Frame: 1 hour
VIDIAC (Videolaryngoscopic Intubation and Difficult Airway Classification) Score from -1 (best) to 5 (worst)
1 hour
Number of intubation attempts
Time Frame: 1 hour
Observed during airway management
1 hour
Number of laryngoscopy attempts
Time Frame: 1 hour
Observed during airway management
1 hour
Airway related adverse events
Time Frame: 1 hour
Number of participants with airway related adverse events observed during airway management
1 hour
Hypoxaemia
Time Frame: 1 hour
Number of participants with a drop in peripheral oxygen saturation during airway management
1 hour
Hypotension
Time Frame: 1 hour
Number of participants with hypotension observed during airway management
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Petzoldt, MD, Universitatsklinikum Hamburg-Eppendorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2022

Primary Completion (Actual)

July 31, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

August 22, 2022

First Submitted That Met QC Criteria

August 27, 2022

First Posted (Actual)

August 30, 2022

Study Record Updates

Last Update Posted (Actual)

September 26, 2023

Last Update Submitted That Met QC Criteria

September 24, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-100868-BO-ff

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anesthesia

Clinical Trials on hyperangulated videolaryngoscope

Subscribe